Kirkland Advises Altaris on Acquisition of Minaris Regenerative Medicine

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

Not stated

What the figure measures

Not stated

Client

Not stated

Counterparties

Altaris, LLC (Buy-side)
Resonac Corporation (Sell-side)
Minaris Regenerative Medicine (Target)